secwatch.observer — SEC 8-K summary
======================================

Issuer:     TriSalus Life Sciences, Inc. (TLSI)
CIK:        0001826667
Form:       8-K
Filed at:   2023-04-05T23:59:59+00:00
Accession:  0001104659-23-042182
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MedTech Acquisition amends merger with TriSalus to assume restricted stock unit awards
--------------------------------------------------------------------------------

- Amendment allows MTAC to assume TriSalus' outstanding RSUs, converting them into MTAC RSUs at the Exchange Ratio.
- RSU conversion: number of MTAC shares = TriSalus RSU shares × Exchange Ratio, rounded down.
- Definition of Acquiror Transaction Expenses revised to exclude certain fees from Future PIPE Investment.
- Company acknowledges that grant of Company RSUs does not breach representations or warranties.
- No other changes to the Merger Agreement; all other terms remain in full force.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1826667/000110465923042182/0001104659-23-042182-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1826667/000110465923042182/tm2311821d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-042182

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer